Skip to main content

stock

MDCXW · Medicus Pharma Ltd.

What Medicus Pharma Ltd. reports to the SEC, read from its filings.

Open in the app

Price

The live MDCXW price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on MDCXW.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
63,180,610 as of 2026-08-10 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
-209.0%

Health

Current ratio
1.6x
Debt/equity
—

Deep value

NCAV
-$11.86M
NCAV per share
-$0.19
Price/NCAV
Locked
NNWC
-$13.67M
NNWC per share
-$0.22
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$11.48M-$11.62M
10-Q filed 2026-08-12
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$8.60M-$9.04M
10-Q filed 2026-05-14
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$23.22M-$15.07M
10-K filed 2026-03-25
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$15-$20.94M
10-Q filed 2025-11-14
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$6.02M-$6.18M
10-Q filed 2026-08-12
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$5.13M-$5.10M
10-Q filed 2026-05-14
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$3.59M-$3.54M
10-K filed 2026-03-25
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$2.33M-$2.28M
10-Q filed 2025-11-14
Assets
$27.12M
Equity
-$1.76M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$34.36M-$47.28M—
2024-12-31—-$11.18M-$11.16M—
2023-12-31—-$4.73M-$5.31M—

Company filings

since Fri Jan 30 · 44 offering filings in 12 months · since Fri Jan 2

events

  • Agreement ended

    Agreement ended
    Sep 148-K
  • Unregistered share sale

    Unregistered share sale
    Sep 118-K
  • Material agreement

    Material agreement
    Sep 38-K
  • Shareholder vote results

    Shareholder vote results
    Jun 48-K
  • Material agreement, New debt, Listing standard notice

    Material agreementNew debtListing standard notice
    May 278-K
  • Material agreement, Listing standard notice

    Material agreementListing standard notice
    Apr 248-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named MDCXW, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about MDCXW.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about MDCXW.

nakagai

Signals on MDCXW come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the MDCXW board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Medicus Pharma Ltd. (MDCXW): SEC filings, financials and insider trades · Nakagai